Biomatcell AB sells innovative concepts
At present Biomatcell AB has five patent families which have originated from the research centre BIOMATCELL and has now sold its share of a joint invention to a partner company.
Through the wholly-owned subsidiary Biomatcell AB, GU Holding develops and commercialises research results from BIOMATCELL, a VINN Excellence Centre of Biomaterials and Cell Therapy. At present, Biomatcell AB has five patent families which have originated from this research and has now sold its share of a joint invention to the partner company which owned the remaining share of the invention and which is now further developing the concept.
Biomatcell AB is conducting discussions with other parties interested in Intellectual Property which are a part of the portfolio the company develops.
For more information:
Portfolio Manager at GU Holding
+46 (0)31-786 5530.